- Generic name
- Ondansetron
- Strength
- 80 mg/100 ml
- Dosage form
- Solution
- Manufactured by
- Ad-din Pharmaceuticals Ltd.
Emigut Solution
About Emigut 80 mg/100 ml Solution
Emigut 80 mg/100 ml solution is a medicine made by Ad-din Pharmaceuticals Ltd. It is also used to prevent and treat nausea and vomiting that can occur after surgery.
There are 74 brands of Ondansetron listed in Bangladesh. The lowest listed price is Periset 16 mg Suppository at ৳ 1 per unit.
What is Emigut 80 mg/100 ml Solution?
Made by Ad-din Pharmaceuticals Ltd., Emigut is a solution whose active ingredient is Ondansetron. Doctors use it in situations such as cancer chemotherapy, radiotherapy and after surgery. Doctors use it to help control nausea and vomiting linked to certain cancer chemotherapy, radiotherapy and surgery. The doctor decides the dose and course based on the patient's condition.
Uses of Emigut
It is also used to prevent and treat nausea and vomiting that can occur after surgery. Emigut is used to help prevent and treat nausea and vomiting in particular medical situations. Emigut solution is used to prevent nausea and vomiting that can occur with cancer chemotherapy and radiotherapy. Your doctor will determine if this medicine is appropriate for your situation.
How to use Emigut
Swallow the solution with a glass of water. Do not change the dose or stop early without asking your doctor. Complete the course exactly as prescribed.
Side effects of Emigut
Some people may experience headache, constipation, or diarrhea when taking Ondansetron. Less common effects can include a feeling of flushing or warmth, hiccups, or changes in liver enzymes. Common side effects of Ondansetron include headache, constipation and diarrhea. Tell your doctor or nurse promptly if you feel unwell after the solution. Tell your doctor if you notice any side effect, especially one that is severe or does not go away.
Safety and precautions
Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. Ondansetron was not mutagenic in standard tests for mutagenicity. The use of Ondansetron in patients following abdominal surgery or in patients with chemotherapy-induced nausea and vomiting may mask a progressive ileus and/or gastric distension. Keep out of reach of children.
Frequently asked questions
What is Emigut used for?
It is also used to prevent and treat nausea and vomiting that can occur after surgery. Emigut is used to help prevent and treat nausea and vomiting in particular medical situations.
How should I take Emigut?
Swallow the solution with a glass of water. Do not change the dose or stop early without asking your doctor.
What should I watch for while using Emigut?
Some people may experience headache, constipation, or diarrhea when taking Ondansetron. Less common effects can include a feeling of flushing or warmth, hiccups, or changes in liver enzymes.
Who should be careful with Emigut?
Ondansetron is not a drug that stimulates gastric or intestinal peristalsis. Ondansetron was not mutagenic in standard tests for mutagenicity.
Indications
- Prevention of nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.
- Prevention and treatment of post-operative nausea and vomiting.
- Prevention of radiotherapy-induced nausea and vomiting.
Pharmacology
Dosage & Administration
Adults, Pediatric patients (6 months to 18 years):
- 8 mg tablet/orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: Initial Dose: 8 mg orally 1 to 2 hours before radiotherapy. Post Radiotherapy: 8 mg orally every 8 hours for up to 5 days after a course of treatment.
- 4 mg orodispersible tablet: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose.
- Injection: Three 0.15 mg/kg doses, up to a maximum of 16 mg per dose, infused intravenously over 15 minutes.
Adults:
- 8 mg tablet/orodispersible tablet: 16 mg given as two 8 mg tablets
- 4 mg orodispersible tablet: 16 mg
- Injection: 4 mg
Pediatrics (40 kg): Injection: 0.1 mg/kg
Chemotherapy-induced Nausea and Vomiting-
Adults/Geriatric/Child of 12 years or over:
- Highly emetogenic cancer chemotherapy: 30 ml (24 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy.
- Moderate emetogenic cancer chemotherapy: 10 ml (8 mg) Ondansetron Oral Solution administered 30 minutes before start of emetogenic chemotherapy. A further 10 ml dose should be administered after 8 hours of the first dose. One 10 ml dose should be administered twice a day (every 12 hours) for 1-2 days after completion of chemotherapy.
Oral solution:
Radiotherapy induced Nausea and Vomiting (Adults/Geriatric/Child of 12 years or over):- The recommended oral dosage: 10 ml (8 mg) Ondansetron Oral Solution 3 times daily.
- For total body irradiation: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before each fraction of radiotherapy administered each day.
- For single high-dose fraction radiotherapy to the abdomen: one 10 ml Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for 1 to 2 days after completion of radiotherapy.
- For daily fractionated radiotherapy to the abdomen: 10 ml (8-mg) Ondansetron Oral Solution should be administered 1 to 2 hours before radiotherapy, with subsequent doses every 8 hours after the first dose for each day radiotherapy is given.
- 20 ml (16 mg) Ondansetron Oral Solution 1 hour before induction of anesthesia
Oral Soluble Film:
Prevention of nausea and vomiting associated with highly emetogenic cancer chemotherapy:- Adult oral dose: 24 mg given successively as three 8 mg films 30 minutes before the start of chemotherapy.
- Adults and pediatric patients 12 years of age and older: One 8 mg film 30 minutes before chemotherapy followed by an 8 mg dose 8 hours later. Administer one 8 mg film twice a day (every 12 hours) for 1 to 2 days after completion of chemotherapy.
- Pediatric patients 4 through 11 years of age: One 4 mg film three times a day. Administer the first dose 30 minutes before chemotherapy, with subsequent doses 4 and 8 hours later. Administer one 4 mg film three times a day (every 8 hours) for 1 to 2 days after completion of chemotherapy.
- Prevention of nausea and vomiting associated with radiotherapy: The adult dosage is one 8 mg film three times a day.
- Postoperative nausea and vomiting: The adult dose is 16 mg given successively as two 8 mg films 1 hour before anesthesia.
Interaction
Contraindications
Side Effects
Pregnancy & Lactation
Reproduction studies have been performed in pregnant rats and rabbits at daily oral doses up to 15 and 30 mg/kg per day, respectively, and have revealed no evidence of impaired fertility or harm to the fetus due to Ondansetron. There are, however, no adequate and well-controlled studies in pregnant women. Ondansetron is excreted in the breast milk of rats. So caution should be exercised when Ondansetron is administered to a nursing women.
Precautions & Warnings
Storage Conditions
Alternative brands of Ondansetron
Other brands with the same generic name, cheapest first.
Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.